NEW YORK – Buffalo Congressman Chris Collins will appear once again in a Manhattan courtroom on Thursday.
Collins, who served on the board of Innate Immunotherapeutics Limited, an Australian biotechnology company, was charged with insider trading in 2018.
A criminal complaint alleges Collins learned of the negative results of some clinical trials for the company, and told his son Cameron about the results before they were released to the public.
This week the congressman was denied a request to review materials in the case.
Collins said that the materials would show that investigators violated a constitutional provision that restricts official questions into legislative matters.
The judge ruled that the searches didn’t involve any official accounts of Congressional offices.